ContractDeposit Agreement • July 20th, 2015 • Citibank,N.A./ADR • Pharmaceutical preparations • New York
AMENDED AND RESTATED DEPOSIT AGREEMENT, dated as of February 6, 2015 (this "Deposit Agreement"), among ASTRAZENECA PLC (the "Company") and its successors, CITIBANK, N.A., as successor depositary hereunder (the "Depositary"), and all Holders and Beneficial Owners from time to time of American Depositary Receipts ("ADRs") issued hereunder evidencing American Depositary Shares ("ADSs") representing deposited Shares (as defined below).
ASTRAZENECA PLC AND CITIBANK, N.A., As Depositary, AND ALL HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES OUTSTANDING UNDER THE TERMS OF THE AMENDED AND RESTATED DEPOSIT AGREEMENT, DATED AS OF FEBRUARY 6, 2015 Amendment No. 1 to Amended...Amended and Restated Deposit Agreement • July 20th, 2015 • Citibank,N.A./ADR • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO AMENDED AND RESTATED DEPOSIT AGREEMENT dated as of [_______] (the “Amendment”), by and among ASTRAZENECA PLC, a company incorporated in England (the “Company”), Citibank, N.A., a national banking association organized under the laws of the United States of America (the “Depositary”), and all Holders and Beneficial Owners from time to time of American Depositary Receipts outstanding under the Amended and Restated Deposit Agreement, dated as of February 6, 2015.
